Blood cancer patients undergoing chemotherapy could soon have a reduced dependence on blood transfusions thanks to a new clinical study…
Heads have turned in biotech circles with an ASX filing confirming that Platinum Asset Management has increased its stake in…
Clinical-stage biotech company Syntara (ASX: SNT) has stepped into a transformative year with a renewed focus on drug development. Entering…
Beyond the searing pain of burns, permanent scarring of the skin has a devastating lifelong impact on quality of life.…
Clinical stage drug development company Syntara (ASX:SNT) is set to get a big boost in exposure within the blood cancer…